New Century Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-9,572
Closed -$757K 94
2016
Q3
$757K Sell
9,572
-41,419
-81% -$3.36M 0.66% 65
2016
Q2
$4.25M Sell
50,991
-7,137
-12% -$633K 2.26% 11
2016
Q1
$5.34M Buy
58,128
+93
+0.2% +$8.39K 2.51% 9
2015
Q4
$5.87M Sell
58,035
-6
-0% -$624 2.71% 8
2015
Q3
$5.7M Hold
58,041
2.87% 8
2015
Q2
$6.79M Sell
58,041
-4
-0% -$437 3.12% 4
2015
Q1
$5.7M Buy
58,045
+1,431
+3% +$145K 2.64% 7
2014
Q4
$5.34M Sell
56,614
-37
-0.1% -$3.83K 2.64% 7
2014
Q3
$6.03M Buy
56,651
+2,400
+4% +$235K 3.12% 3
2014
Q2
$4.5M Buy
54,251
+24,485
+82% +$1.91M 2.44% 6
2014
Q1
$2.11M Buy
29,766
+1,100
+4% +$86.3K 1.2% 42
2013
Q4
$2.15M Buy
28,666
+6
+0% +$418 1.29% 36
2013
Q3
$1.8M Buy
+28,660
New +$1.71M 1.23% 36

Other funds holding GILD

New Century Investment Management's GILD Position: Q4 2016 in Review

New Century Investment Management sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 9,572 shares — an estimated $757K sold.

New Century Investment Management first reported a position in GILD in Q3 2013 and held it in 13 quarters. The position peaked at $6.79M in Q2 2015. 1,573 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • New Century Investment Management reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
  • New Century Investment Management sold 9,572 Gilead Sciences shares in Q4 2016, an estimated $757K.
  • New Century Investment Management first reported a position in Gilead Sciences in Q3 2013 and held it in 13 quarters.
  • New Century Investment Management's Gilead Sciences position peaked at $6.79M in Q2 2015.
  • 1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on New Century Investment Management's 13F filing for Q4 2016, filed 25 Jan 2017.